Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah L Elliott

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
British Journal of Haematology|November 19, 2010
Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemiaSarah L Elliott, Clark Crawford, Evan Mulligan, et al.
Cancers|October 14, 2023
Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical SignallingEvan A Mulligan, Susan J Tudhope, Jill E Hunter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemiaElaine Willmore, Sarah L Elliott, Tryfonia Mainou-Fowler, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
British Journal of Haematology|November 19, 2010
Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemiaSarah L Elliott, Clark Crawford, Evan Mulligan, et al.
Cancers|October 14, 2023
Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical SignallingEvan A Mulligan, Susan J Tudhope, Jill E Hunter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemiaElaine Willmore, Sarah L Elliott, Tryfonia Mainou-Fowler, et al.
Pageof 3